Programs

Episodes 1-16 of 29

- Edward Chu, MD
  Peer
- Michael J. Overman, MD
  Peer
5
CME/CE
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
0.25 credits
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic...
0.25 credits
- Paul P. Doghramji, MD, FAAFP
  Peer
- Corey S. Cutler, MD, MPH, FRCPC
  Peer
- Doris M. Ponce, MD
  Peer
6
CME/CE
Breakthroughs and Innovations: Managing Complex Cases in Graft-versus-Host Disease
Breakthroughs and Innovations: Managing Complex Cases in Graft-versus-Host Disease
0.50 credits
Breakthroughs and Innovations: Managing Complex Cases in Graft-versus-Host Di...
0.50 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
6
CME/CE
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Co...
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
- Josep Tabernero, MD, PhD
  Peer
8
CME/CE
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Ca...
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Linda R. Duska, MD, MPH
  Peer
14
CME/CE
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
- Mark A. Socinski, MD
  Peer
- Alexander Drilon, MD
  Peer
10
CME/CE
Keeping Pace: Advances in RET Fusion-Positive NSCLC
Keeping Pace: Advances in RET Fusion-Positive NSCLC
0.25 credits
Keeping Pace: Advances in RET Fusion-Positive NSCLC
0.25 credits
- Mark A. Socinski, MD
  Peer
- Helena Yu, MD
  Peer
8
CME/CE
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
0.25 credits
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
0.25 credits
- Mark A. Socinski, MD
  Peer
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
5
CME/CE
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
0.25 credits
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lu...
0.25 credits
- William J. Gradishar MD, FASCO, FACP
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
6
CME/CE
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
0.25 credits
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Met...
0.25 credits
- Mark A. Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
4
CME/CE
Keeping Pace: The Role of Immunotherapy After Disease Progression
Keeping Pace: The Role of Immunotherapy After Disease Progression
0.25 credits
Keeping Pace: The Role of Immunotherapy After Disease Progression
0.25 credits
- Mark A. Socinski, MD
  Peer
- Suresh S. Ramalingam, MD
  Peer
7
CME/CE
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
0.25 credits
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
0.25 credits
- Warner K. Huh, MD
  Peer
- Deborah K. Armstrong, MD
  Peer
- Robert L. Coleman, MD, FACOG, FACS
  Peer
13
CME/CE
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
0.25 credits
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
0.25 credits
- Peter H. O'Donnell, MD
  Peer
- Daniel P. Petrylak, MD
  Peer
13
CME/CE
Keeping Pace: Emerging Treatment Considerations in Metastatic Urothelial Cancer
Keeping Pace: Emerging Treatment Considerations in Metastatic Urothelial Cancer
0.25 credits
Keeping Pace: Emerging Treatment Considerations in Metastatic Urothelial Cancer
0.25 credits
- Mark A. Socinski, MD
  Peer
2
CME/CE
Key Highlights from the Latest Clinical Trials in Lung Cancer
Key Highlights from the Latest Clinical Trials in Lung Cancer
0.25 credits
Key Highlights from the Latest Clinical Trials in Lung Cancer
0.25 credits
- John J. Russell, MD
  Peer
- Richard Wender, MD
  Peer
9
Project Oncology®
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
- Brian P. McDonough, MD, FAAFP
  Peer
4
Project Oncology®
Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer
Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer
Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer